Diagnosing, managing, and preventing salivary gland disorders.
Ship
J A
JA
Department of Oral Medicine and The Bluestone Center for Clinical Research, New York University College of Dentistry, New York 10010-4046, USA. jonathan.ship@nyu.edu
D000328:Adult; D001327:Autoimmune Diseases / Q000150:complications; D001706:Biopsy; D018679:Cholinergic Agonists / Q000627:therapeutic use; D003952:Diagnostic Imaging; D004194:Disease; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D009910:Oral Hygiene; D011878:Radiotherapy / Q000009:adverse effects; D012463:Saliva / Q000737:chemistry / Q000378:metabolism; D012464:Saliva, Artificial / Q000627:therapeutic use; D012466:Salivary Gland Diseases / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D012468:Salivary Gland Neoplasms / Q000175:diagnosis / Q000628:therapy; D012636:Secretory Rate; D012859:Sjogren's Syndrome / Q000628:therapy; D011795:Surveys and Questionnaires; D014987:Xerostomia / Q000175:diagnosis / Q000209:etiology
D018679:Cholinergic Agonists; D012464:Saliva, Artificial